Who Should Attend?

  • Leaders of emerging biotech companies focused in rare diseases looking to connect with patient communities, investors and/or partners and learn from experts about the best potential paths forward.
  • Research scientists eager to see their rare disease discoveries translated into therapies by forming a new company or licensing to an existing biotech or pharmaceutical partner
  • Executives from global pharmaceutical and biotechnology companies eager to connect with disease advocacy groups and partner with startups and academics with potential licensing opportunities
  • Disease research advocates at non-profit organizations thinking about starting for-profit companies to raise capital and advance new therapeutics for their disease
  • Venture investors eager to identify, cultivate and invest in new opportunities in the rare disease area
  • Non-profit disease advocacy organizations eager to explore new models for funding research, including royalty agreements and investments in companies

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!